TREPULMIX Trademark

Trademark Overview

On Wednesday, November 18, 2020, a trademark application was filed for TREPULMIX with the United States Patent and Trademark Office. The USPTO has given the TREPULMIX trademark a serial number of 79300252. The federal status of this trademark filing is REGISTERED as of Tuesday, November 16, 2021. This trademark is owned by AOP Orphan Pharmaceuticals AG. The TREPULMIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and medical preparations for the treatment of chronic pulmonary hypertension; pharmaceutical preparations and medical preparations for the treatment of chronic, thromboembolic pulmonary hypertension
trepulmix

General Information

Serial Number79300252
Word MarkTREPULMIX
Filing DateWednesday, November 18, 2020
Status700 - REGISTERED
Status DateTuesday, November 16, 2021
Registration Number6557480
Registration DateTuesday, November 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and medical preparations for the treatment of chronic pulmonary hypertension; pharmaceutical preparations and medical preparations for the treatment of chronic, thromboembolic pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAOP Orphan Pharmaceuticals GmbH
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressAT

Trademark Events

Event DateEvent Description
Monday, May 30, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 7, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 6, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 16, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, December 18, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 26, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 16, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Sunday, August 29, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 11, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 11, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, May 30, 2021REFUSAL PROCESSED BY IB
Saturday, May 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 5, 2021REFUSAL PROCESSED BY MPU
Sunday, May 2, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, May 1, 2021NON-FINAL ACTION WRITTEN
Friday, April 30, 2021ASSIGNED TO EXAMINER
Tuesday, December 22, 2020APPLICATION FILING RECEIPT MAILED
Friday, December 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

trepulmix preparations pulmonary hypertension chronic treatment pharmaceutical medical thromboembolic